Sitagliptin phosphate monohydrate
Sitagliptin ( trade name Januvia) is an orally bioavailable dipeptidyl peptidase-4 (DPP-4) inhibitor for the treatment of type-2 diabetes. Sitagliptin has been approved by the U.S Food and Drug Administration on Oct 17, 2006.
Product Name: Sitagliptin phosphate monohydrate
CAS Number: 654671-77-9
Molecular Weight:  523.32806
Molecular Formula:  C16H20F6N5O6P
Purity (HPLC): ≥99%
Shipping Conditions: Room temperature.
Storage Conditions: Refrigerated.
Regulatory Statement:  For Research Use Only.